BMI OrganBank

BMI OrganBank is a medical technology company dedicated to improving organ transplantation through innovative solutions for organ and tissue perfusion and preservation. Established in 2020, the company collaborates with leading academic institutions, including the Duke Ex Vivo Organ Lab and the Wake Forest Institute for Regenerative Medicine, to develop advanced technologies aimed at addressing the shortage of transplantable organs. The company offers a range of products designed to enhance organ assessment and preservation. Notable offerings include the OrganBank Kidney device, which utilizes room temperature machine perfusion for better kidney function evaluation, and the DEVOL Solution, an acellular perfusate that supports organ viability. Additionally, BMI OrganBank provides tools like the OrganBank Monitor for real-time organ assessment and BMI OrganIQ, an AI-based tool for predicting transplant outcomes. Their solutions are tailored for organ banks, transplant centers, and medical researchers, with a commitment to reducing organ discard rates and expanding the availability of viable organs for transplantation.

• Employees25
• Founded2005